- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04791917
Marijuana Use, Strength Training, and Alcohol Consumption (MUSTAC) Study
July 5, 2023 updated by: University of Florida
Self-medication of pain by consuming alcohol and marijuana is common.
However, the research regarding pain as a determinant for alcohol and marijuana use has relied on laboratory pain induction paradigms with limited clinical relevance.
The study will assess demand for alcohol and marijuana before and after delayed onset muscle soreness (DOMS) induction in co-users.
This will provide a clinically relevant, but time-limited, model for the effects of musculoskeletal pain on demand.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida Center for Pain Research and Behavioral Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age ≥ 21 years;
- English-speaking
- Self-identify as White/Caucasian or Black/African American
- Own a smartphone with cellular/data plan
- Regularly co-use alcohol and smoked marijuana as indicated by scores of ≥3 on item 1 of the CUDIT-R and AUDIT.
- Willing and able to give informed consent
Exclusion Criteria:
- Participation in biceps-specific conditioning program in the past 6 months*
- Self-reported wrist/hand, elbow, or shoulder pain the past 3 months
- Chronic medical condition that may affect pain perception (e.g. diabetes, fibromyalgia, headaches)
- Self-reported kidney dysfunction, muscle damage, or major psychiatric disorder
- Medical marijuana prescription
- Consumption of marijuana using only non-inhalational methods (e.g. edibles, tinctures, or cannabidiol oil)
- Score of ≥ 10 on Patient Health Questionnaire-9 (moderate depression)
- Women who are pregnant, trying to become pregnant, or breastfeeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Delayed Onset Muscle Soreness Induction
Participants will complete an exercise session designed to induce delayed onset muscle soreness in the biceps
|
Muscle lengthening biceps exercise
|
Sham Comparator: Sham Delayed Onset Muscle Soreness Induction
Participants will complete an exercise session that is unlikely to induce delayed onset muscle soreness in the biceps
|
Muscle shortening biceps exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol Demand: Breakpoint
Time Frame: 48 hours after exercise
|
Changes in breakpoint of alcohol demand, assessed using the Alcohol Purchase Task.
Breakpoint indicates the drink price at which participants report no alcohol consumption.
Values represent difference scores derived from breakpoint values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Alcohol Demand: Omax
Time Frame: 48 hours after exercise
|
Changes in Omax, assessed using the Alcohol Purchase Task.
Omax reflects the highest total amount in dollars that a participant would spend on alcohol-containing beverages.
Values represent difference scores derived from log-transformed Omax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Alcohol Demand: Pmax
Time Frame: 48 hours after exercise
|
Changes in Pmax, assessed using the Alcohol Purchase Task.
Pmax reflects the price point at which demand for alcohol becomes elastic (i.e., declines in response to increasing price).
Values represent difference scores derived from log-transformed Pmax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Alcohol Demand: Essential Value
Time Frame: 48 hours after exercise
|
Changes in Essential Value, assessed using the Alcohol Purchase Task.
Essential Value represents the reinforcing efficacy of alcohol, such that higher Essential Value indicates greater reinforcing efficacy.
Values represent difference scores derived from Essential Values coded so that positive numbers indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Cannabis Demand: Intensity
Time Frame: 48 hours after exercise
|
Changes in intensity of cannabis demand, assessed using the Marijuana Purchase Task.
Intensity reflects the number of joints that would hypothetically be consumed if they were free.
Values represent difference scores derived from log-transformed intensity values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Cannabis Demand: Breakpoint
Time Frame: 48 hours after exercise
|
Changes in breakpoint of cannabis demand, assessed using the Marijuana Purchase Task.
Breakpoint indicates the joint price at which participants report no cannabis consumption.
Values represent difference scores derived from breakpoint values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Cannabis Demand: Omax
Time Frame: 48 hours after exercise
|
Changes in Omax, assessed using the Marijuana Purchase Task.
Omax reflects the highest total amount that a participant would spend on cannabis.
Values represent difference scores derived from log-transformed Omax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Cannabis Demand: Pmax
Time Frame: 48 hours after exercise
|
Changes in Pmax, assessed using the Marijuana Purchase Task.
Pmax reflects the price point at which demand for cannabis becomes elastic (i.e., declines in response to increasing price).
Values represent difference scores derived from log-transformed Pmax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Cannabis Demand: Essential Value
Time Frame: 48 hours after exercise
|
Changes in Essential Value, assessed using the Marijuana Purchase Task.
Essential Value represents the reinforcing efficacy of cannabis, such that higher Essential Value indicates greater reinforcing efficacy.
Values represent difference scores derived from Essential Values coded so that positive numbers indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Alcohol Demand: Intensity
Time Frame: 48 hours after exercise
|
Changes in intensity of alcohol demand, assessed using the Alcohol Purchase Task.
Intensity reflects the number of drinks that would hypothetically be consumed if they were free.
Values represent difference scores derived from log-transformed number of drinks coded so that positive values indicate an increase in the demand index from baseline to follow-up.
|
48 hours after exercise
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jeff Boissoneault, PhD, University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 28, 2020
Primary Completion (Actual)
May 10, 2022
Study Completion (Actual)
May 10, 2022
Study Registration Dates
First Submitted
March 9, 2021
First Submitted That Met QC Criteria
March 9, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 5, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB202000058-N
- 1F31AA028696-01A1 (U.S. NIH Grant/Contract)
- AGR DTD 02-17-2020 (Other Grant/Funding Number: Research Society on Alcoholism)
- UFCAREDAG002 (Other Grant/Funding Number: UF Center for Addiction Research and Education)
- 00045887 (Other Grant/Funding Number: UF Dept of Clinical and Health Psychology)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Vastra Gotaland RegionActive, not recruitingPain, Chronic | Widespread Chronic PainSweden
-
Washington University School of MedicineCompletedHip Pain Chronic | Back Pain | Chronic Pain | Knee Pain ChronicUnited States
Clinical Trials on Eccentric Biceps Flexion
-
Norwegian School of Sport SciencesUniversity of Oslo; Oslo University Hospital; University of Copenhagen; Université... and other collaboratorsCompletedRecovery | Muscle Damage | Muscle Stiffness | Cell Structure Alteration | Calcium CyclingNorway
-
University of ChicagoCompletedChronic Refractive Bicipital PainUnited States
-
Panam ClinicUniversity of OttawaCompletedRotator Cuff Tear | Long Head of Biceps Brachii LesionsCanada
-
Rush University Medical CenterWithdrawn
-
Assiut UniversityNot yet recruiting
-
University of AlbertaTerminated
-
University of ThessalyCompleted
-
University of ChicagoCompletedType 2 SLAP LesionsUnited States
-
HealthPartners InstituteUniversity of MinnesotaTerminated
-
West Penn Allegheny Health SystemCompleted